Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Comments
Loading...
Abbott Laboratories Analyst Ratings and Price Targets | NYSE:ABT | Benzinga
Abbott Laboratories has a consensus price target of $132.79 based on the ratings of 29 analysts. The high is $160 issued by Citigroup on March 4, 2025. The low is $104 issued by Goldman Sachs on July 25, 2022. The 3 most-recent analyst ratings were released by B of A Securities, Citigroup, and Goldman Sachs on March 10, 2025, March 4, 2025, and March 4, 2025, respectively. With an average price target of $154.67 between B of A Securities, Citigroup, and Goldman Sachs, there's an implied 20.57% upside for Abbott Laboratories from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
B of A Securities
Citigroup
Goldman Sachs
Barclays
RBC Capital
1calculated from analyst ratings
Analyst Ratings for Abbott Laboratories
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 03/10/2025 | Buy Now | 16.93% | B of A Securities | Travis Steed60% | $133 → $150 | Maintains | Buy | Get Alert |
| 03/04/2025 | Buy Now | 24.73% | Citigroup | Joanne Wuensch75% | $135 → $160 | Maintains | Buy | Get Alert |
| 03/04/2025 | Buy Now | 20.05% | Goldman Sachs | David Roman37% | $138 → $154 | Maintains | Buy | Get Alert |
| 01/27/2025 | Buy Now | 23.17% | Barclays | Matt Miksic68% | $149 → $158 | Maintains | Overweight | Get Alert |
| 01/23/2025 | Buy Now | 5.24% | RBC Capital | Shagun Singh58% | $135 → $135 | Reiterates | Outperform → Outperform | Get Alert |
| 01/23/2025 | Buy Now | 6.02% | Wells Fargo | Lawrence Biegelsen41% | $133 → $136 | Maintains | Overweight | Get Alert |
| 01/23/2025 | Buy Now | 5.24% | Stifel | Rick Wise74% | $130 → $135 | Maintains | Buy | Get Alert |
| 01/23/2025 | Buy Now | 15.37% | UBS | Danielle Antalffy52% | $146 → $148 | Maintains | Buy | Get Alert |
| 01/21/2025 | Buy Now | 5.24% | RBC Capital | Shagun Singh58% | $135 → $135 | Reiterates | Outperform → Outperform | Get Alert |
| 11/05/2024 | Buy Now | 16.15% | Barclays | Matt Miksic68% | $143 → $149 | Maintains | Overweight | Get Alert |
| 10/17/2024 | Buy Now | 7.58% | Bernstein | Lee Hambright68% | $133 → $138 | Maintains | Outperform | Get Alert |
| 10/17/2024 | Buy Now | 13.81% | UBS | Danielle Antalffy52% | $143 → $146 | Maintains | Buy | Get Alert |
| 10/17/2024 | Buy Now | -2.56% | Jefferies | Matthew Taylor67% | $120 → $125 | Maintains | Hold | Get Alert |
| 10/17/2024 | Buy Now | 1.34% | Mizuho | Anthony Petrone65% | $115 → $130 | Maintains | Neutral | Get Alert |
| 10/17/2024 | Buy Now | 3.68% | Piper Sandler | Adam Maeder65% | $131 → $133 | Maintains | Overweight | Get Alert |
| 10/17/2024 | Buy Now | -8.79% | Morgan Stanley | David Lewis70% | $107 → $117 | Maintains | Equal-Weight | Get Alert |
| 10/14/2024 | Buy Now | 0.56% | Raymond James | Jayson Bedford69% | $122 → $129 | Maintains | Outperform | Get Alert |
| 10/08/2024 | Buy Now | 1.34% | RBC Capital | Shagun Singh58% | $125 → $130 | Maintains | Outperform | Get Alert |
| 10/08/2024 | Buy Now | 1.34% | Oppenheimer | Suraj Kalia54% | → $130 | Initiates | → Outperform | Get Alert |
| 10/01/2024 | Buy Now | -3.34% | Evercore ISI Group | Vijay Kumar53% | $120 → $124 | Maintains | Outperform | Get Alert |
| 09/26/2024 | Buy Now | -6.45% | Jefferies | Raj Denhoy75% | $120 → $120 | Reiterates | Hold → Hold | Get Alert |
| 09/19/2024 | Buy Now | 2.12% | Piper Sandler | Adam Maeder65% | → $131 | Initiates | → Overweight | Get Alert |
| 08/27/2024 | Buy Now | -6.45% | Jefferies | Raj Denhoy75% | $112 → $120 | Maintains | Buy | Get Alert |
| 08/22/2024 | Buy Now | -1% | Citigroup | Joanna Wiensch63% | $119 → $127 | Maintains | Buy | Get Alert |
| 07/29/2024 | Buy Now | 11.47% | Barclays | Matt Miksic68% | $140 → $143 | Maintains | Overweight | Get Alert |
| 07/02/2024 | Buy Now | -6.45% | Evercore ISI Group | Vijay Kumar53% | $125 → $120 | Maintains | Outperform | Get Alert |
| 06/04/2024 | Buy Now | -2.56% | RBC Capital | Shagun Singh58% | $125 → $125 | Reiterates | Outperform → Outperform | Get Alert |
| 05/30/2024 | Buy Now | -5.68% | Goldman Sachs | David Roman37% | → $121 | Initiates | → Buy | Get Alert |
| 05/22/2024 | Buy Now | -7.23% | Citigroup | Joanna Wiensch63% | $128 → $119 | Maintains | Buy | Get Alert |
| 04/22/2024 | Buy Now | 9.14% | Barclays | Matt Miksic68% | $141 → $140 | Maintains | Overweight | Get Alert |
| 04/18/2024 | Buy Now | -2.56% | RBC Capital | Shagun Singh58% | $128 → $125 | Maintains | Outperform | Get Alert |
| 04/04/2024 | Buy Now | -2.56% | Evercore ISI Group | Vijay Kumar53% | $120 → $125 | Maintains | Outperform | Get Alert |
| 04/03/2024 | Buy Now | -0.22% | Citigroup | Joanne Wuensch75% | $126 → $128 | Maintains | Buy | Get Alert |
| 02/14/2024 | Buy Now | -0.22% | RBC Capital | Shagun Singh58% | $128 → $128 | Reiterates | Outperform → Outperform | Get Alert |
| 01/26/2024 | Buy Now | 9.92% | Barclays | Matt Miksic68% | $133 → $141 | Maintains | Overweight | Get Alert |
| 01/25/2024 | Buy Now | -0.22% | RBC Capital | Shagun Singh58% | $128 → $128 | Reiterates | Outperform → Outperform | Get Alert |
| 01/25/2024 | Buy Now | -1.78% | Citigroup | Joanne Wuensch75% | $123 → $126 | Maintains | Buy | Get Alert |
| 01/25/2024 | Buy Now | -1% | Raymond James | Jayson Bedford69% | $124 → $127 | Maintains | Outperform | Get Alert |
| 01/11/2024 | Buy Now | -0.22% | RBC Capital | Shagun Singh58% | $119 → $128 | Maintains | Outperform | Get Alert |
| 01/03/2024 | Buy Now | -3.34% | Raymond James | Jayson Bedford69% | $110 → $124 | Maintains | Outperform | Get Alert |
| 12/13/2023 | Buy Now | -5.68% | Wells Fargo | Lawrence Biegelsen41% | $116 → $121 | Maintains | Overweight | Get Alert |
| 12/11/2023 | Buy Now | -4.12% | Citigroup | Joanne Wuensch75% | $122 → $123 | Maintains | Buy | Get Alert |
| 10/19/2023 | Buy Now | 3.68% | Barclays | Matt Miksic68% | $132 → $133 | Maintains | Overweight | Get Alert |
| 10/19/2023 | Buy Now | -16.59% | Morgan Stanley | David Lewis70% | $112 → $107 | Maintains | Equal-Weight | Get Alert |
| 10/19/2023 | Buy Now | -9.57% | Wells Fargo | Lawrence Biegelsen41% | $136 → $116 | Maintains | Overweight | Get Alert |
| 10/19/2023 | Buy Now | -14.25% | Raymond James | Jayson Bedford69% | $123 → $110 | Maintains | Outperform | Get Alert |
| 10/02/2023 | Buy Now | -4.9% | Citigroup | Joanne Wuensch75% | $130 → $122 | Maintains | Buy | Get Alert |
| 07/24/2023 | Buy Now | 2.9% | Barclays | Matt Miksic68% | $127 → $132 | Maintains | Overweight | Get Alert |
| 07/21/2023 | Buy Now | -12.69% | Morgan Stanley | David Lewis70% | $112 → $112 | Reiterates | Equal-Weight → Equal-Weight | Get Alert |
| 07/21/2023 | Buy Now | -10.35% | Mizuho | Anthony Petrone65% | $110 → $115 | Assumes | Neutral → Neutral | Get Alert |
| 07/21/2023 | Buy Now | — | Wolfe Research | Mike Polark54% | — | Upgrade | Underperform → Peer Perform | Get Alert |
| 05/30/2023 | Buy Now | -12.69% | Morgan Stanley | David Lewis70% | → $112 | Assumes | → Equal-Weight | Get Alert |
| 04/20/2023 | Buy Now | 1.34% | UBS | Matthew Korn46% | $117 → $130 | Maintains | Buy | Get Alert |
| 04/20/2023 | Buy Now | -4.12% | Raymond James | Jayson Bedford69% | $116 → $123 | Maintains | Outperform | Get Alert |
| 04/20/2023 | Buy Now | -1% | Barclays | Matt Miksic68% | $125 → $127 | Maintains | Overweight | Get Alert |
| 04/20/2023 | Buy Now | 1.34% | Citigroup | Joanne Wuensch75% | $125 → $130 | Maintains | Buy | Get Alert |
| 04/17/2023 | Buy Now | 1.34% | BTIG | Ryan Zimmerman72% | $125 → $130 | Maintains | Buy | Get Alert |
| 04/17/2023 | Buy Now | -9.57% | Raymond James | Jayson Bedford69% | $123 → $116 | Maintains | Outperform | Get Alert |
| 04/10/2023 | Buy Now | 6.02% | Wells Fargo | Lawrence Biegelsen41% | $140 → $136 | Maintains | Overweight | Get Alert |
| 04/05/2023 | Buy Now | 6.02% | Wells Fargo | Larry Biegelsen69% | $140 → $136 | Maintains | Overweight | Get Alert |
| 03/29/2023 | Buy Now | -8.79% | UBS | Danielle Antalffy52% | → $117 | Assumes | → Buy | Get Alert |
| 01/27/2023 | Buy Now | -2.56% | Barclays | Matt Miksic68% | $122 → $125 | Maintains | Overweight | Get Alert |
| 01/26/2023 | Buy Now | -2.56% | BTIG | Marie Thibault63% | $120 → $125 | Maintains | Buy | Get Alert |
| 01/26/2023 | Buy Now | -2.56% | Stifel | Rick Wise74% | $110 → $125 | Maintains | Buy | Get Alert |
| 01/26/2023 | Buy Now | -4.12% | Raymond James | Jayson Bedford69% | $109 → $123 | Maintains | Outperform | Get Alert |
| 01/26/2023 | Buy Now | 2.9% | Bernstein | Lee Hambright68% | $125 → $132 | Maintains | Outperform | Get Alert |
| 01/25/2023 | Buy Now | -16.59% | Wolfe Research | Mike Polark54% | $92 → $107 | Maintains | Underperform | Get Alert |
| 01/24/2023 | Buy Now | -14.25% | Mizuho | Anthony Petrone65% | $105 → $110 | Maintains | Neutral | Get Alert |
| 01/06/2023 | Buy Now | 3.68% | Morgan Stanley | Cecilia Furlong49% | $117 → $133 | Maintains | Overweight | Get Alert |
| 01/04/2023 | Buy Now | -4.9% | Barclays | Matt Miksic68% | $114 → $122 | Maintains | Overweight | Get Alert |
| 12/13/2022 | Buy Now | 1.34% | TD Cowen | Joshua Jennings56% | $130 → $130 | Maintains | Outperform | Get Alert |
| 12/12/2022 | Buy Now | -2.56% | Citigroup | Joanne Wuensch75% | $114 → $125 | Maintains | Buy | Get Alert |
| 10/26/2022 | Buy Now | -18.15% | Mizuho | Anthony Petrone65% | → $105 | Initiates | → Neutral | Get Alert |
| 10/21/2022 | Buy Now | -11.13% | Barclays | Matt Miksic68% | $118 → $114 | Maintains | Overweight | Get Alert |
| 10/21/2022 | Buy Now | -15.03% | Raymond James | Jayson Bedford69% | $117 → $109 | Maintains | Outperform | Get Alert |
| 10/20/2022 | Buy Now | -11.13% | Citigroup | Joanna Wiensch63% | $117 → $114 | Maintains | Buy | Get Alert |
| 10/20/2022 | Buy Now | -6.45% | BTIG | Marie Thibault63% | $123 → $120 | Maintains | Buy | Get Alert |
| 10/20/2022 | Buy Now | -14.25% | Stifel | Rick Wise74% | $126 → $110 | Maintains | Buy | Get Alert |
| 10/20/2022 | Buy Now | -8.01% | JP Morgan | Robbie Marcus67% | $125 → $118 | Maintains | Overweight | Get Alert |
| 10/20/2022 | Buy Now | -8.79% | Morgan Stanley | Cecilia Furlong49% | $126 → $117 | Maintains | Overweight | Get Alert |
| 10/20/2022 | Buy Now | -1.78% | RBC Capital | Shagun Singh58% | $132 → $126 | Maintains | Outperform | Get Alert |
| 10/19/2022 | Buy Now | -14.25% | Evercore ISI Group | Vijay Kumar53% | $114 → $110 | Maintains | Outperform | Get Alert |
| 10/18/2022 | Buy Now | -8.01% | Barclays | Matt Miksic68% | → $118 | Initiates | → Overweight | Get Alert |
| 10/17/2022 | Buy Now | -4.12% | BTIG | Ryan Zimmerman72% | $126 → $123 | Maintains | Buy | Get Alert |
| 10/12/2022 | Buy Now | -14.25% | Jefferies | Matthew Taylor67% | → $110 | Initiates | → Hold | Get Alert |
| 10/11/2022 | Buy Now | -1.78% | Morgan Stanley | Cecilia Furlong49% | $132 → $126 | Maintains | Overweight | Get Alert |
| 10/10/2022 | Buy Now | 9.14% | Wells Fargo | Larry Biegelsen69% | $150 → $140 | Maintains | Overweight | Get Alert |
| 10/09/2022 | Buy Now | 16.93% | Wells Fargo | Larry Biegelsen69% | → $150 | Maintains | Overweight | Get Alert |
| 10/05/2022 | Buy Now | -8.79% | Citigroup | Joanna Wiensch63% | $123 → $117 | Maintains | Buy | Get Alert |
| 08/19/2022 | Buy Now | 9.14% | BTIG | Marie Thibault63% | → $140 | Maintains | Buy | Get Alert |
| 08/04/2022 | Buy Now | 16.93% | Wells Fargo | Larry Biegelsen69% | $155 → $150 | Maintains | Overweight | Get Alert |
| 07/28/2022 | Buy Now | 5.24% | Argus Research | David Toung72% | $150 → $135 | Maintains | Buy | Get Alert |
| 07/27/2022 | Buy Now | -0.22% | UBS | John Sourbeer30% | $142 → $128 | Maintains | Buy | Get Alert |
| 07/25/2022 | Buy Now | -18.93% | Goldman Sachs | Amit Hazan56% | $111 → $104 | Maintains | Sell | Get Alert |
| 07/22/2022 | Buy Now | -2.56% | JP Morgan | Robbie Marcus67% | → $125 | Maintains | Overweight | Get Alert |
| 07/21/2022 | Buy Now | 2.9% | RBC Capital | Shagun Singh58% | $143 → $132 | Maintains | Outperform | Get Alert |
| 07/21/2022 | Buy Now | -4.12% | Citigroup | Joanne Wuensch75% | $125 → $123 | Maintains | Buy | Get Alert |
| 07/21/2022 | Buy Now | 2.9% | Morgan Stanley | Cecilia Furlong49% | $134 → $132 | Maintains | Overweight | Get Alert |
| 07/20/2022 | Buy Now | -12.69% | Evercore ISI Group | Vijay Kumar53% | $116 → $112 | Maintains | Outperform | Get Alert |
| 07/18/2022 | Buy Now | -1.78% | BTIG | Ryan Zimmerman72% | $130 → $126 | Maintains | Buy | Get Alert |
FAQ
What is the target price for Abbott Laboratories (ABT) stock?
The latest price target for Abbott Laboratories (NYSE:ABT) was reported by B of A Securities on March 10, 2025. The analyst firm set a price target for $150.00 expecting ABT to rise to within 12 months (a possible 16.93% upside). 33 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Abbott Laboratories (ABT)?
The latest analyst rating for Abbott Laboratories (NYSE:ABT) was provided by B of A Securities, and Abbott Laboratories maintained their buy rating.
When was the last upgrade for Abbott Laboratories (ABT)?
The last upgrade for Abbott Laboratories happened on July 21, 2023 when Wolfe Research raised their price target to N/A. Wolfe Research previously had an underperform for Abbott Laboratories.
When was the last downgrade for Abbott Laboratories (ABT)?
There is no last downgrade for Abbott Laboratories.
When is the next analyst rating going to be posted or updated for Abbott Laboratories (ABT)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Abbott Laboratories, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Abbott Laboratories was filed on March 10, 2025 so you should expect the next rating to be made available sometime around March 10, 2026.
Is the Analyst Rating Abbott Laboratories (ABT) correct?
While ratings are subjective and will change, the latest Abbott Laboratories (ABT) rating was a maintained with a price target of $133.00 to $150.00. The current price Abbott Laboratories (ABT) is trading at is $128.28, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.